You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Clinical and molecular characterization of HER2amplified-pancreatic cancer
|
|---|---|
| Published in |
Genome Medicine, August 2013
|
| DOI | 10.1186/gm482 |
| Pubmed ID | |
| Authors |
Angela Chou, Nicola Waddell, Mark J Cowley, Anthony J Gill, David K Chang, Ann-Marie Patch, Katia Nones, Jianmin Wu, Mark Pinese, Amber L Johns, David K Miller, Karin S Kassahn, Adnan M Nagrial, Harpreet Wasan, David Goldstein, Christopher W Toon, Venessa Chin, Lorraine Chantrill, Jeremy Humphris, R Scott Mead, Ilse Rooman, Jaswinder S Samra, Marina Pajic, Elizabeth A Musgrove, John V Pearson, Adrienne L Morey, Sean M Grimmond, Andrew V Biankin |
| Abstract |
Pancreatic cancer is one of the most lethal and molecularly diverse malignancies. Repurposing of therapeutics that target specific molecular mechanisms in different disease types offers potential for rapid improvements in outcome. Although HER2 amplification occurs in pancreatic cancer, it is inadequately characterized to exploit the potential of anti-HER2 therapies. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 27% |
| United Kingdom | 1 | 9% |
| Spain | 1 | 9% |
| Unknown | 6 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 5 | 45% |
| Members of the public | 5 | 45% |
| Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 3% |
| Germany | 2 | 2% |
| Italy | 1 | <1% |
| United Kingdom | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 93 | 92% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 23 | 23% |
| Researcher | 14 | 14% |
| Student > Bachelor | 13 | 13% |
| Other | 7 | 7% |
| Student > Master | 6 | 6% |
| Other | 19 | 19% |
| Unknown | 19 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 29 | 29% |
| Biochemistry, Genetics and Molecular Biology | 28 | 28% |
| Agricultural and Biological Sciences | 13 | 13% |
| Computer Science | 2 | 2% |
| Engineering | 2 | 2% |
| Other | 3 | 3% |
| Unknown | 24 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 84. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2022.
All research outputs
#515,868
of 25,775,807 outputs
Outputs from Genome Medicine
#91
of 1,612 outputs
Outputs of similar age
#3,860
of 213,226 outputs
Outputs of similar age from Genome Medicine
#2
of 25 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,612 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.2. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 213,226 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.